Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

InMed Pharmaceuticals Inc C.CAN

Sector: Healthcare | Sub-Sector: Biotechnology
Primary Symbol: C.IN
Alternate Symbol(s):  IMLFF

InMed Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It develops cannabis based therapies through the research and development into the pharmacology of cannabinoids coupled with drug delivery systems.

Get updates on InMed Pharmaceuticals Inc delivered in your email.

Enter your email address:
You are already a member! Please enter your password to sign in.
Please confirm your email address:
Price: $0.115 Volume: 138,563
Change: $-0.02 % Change: -14.81%
Day High/Low: 0.13/0.115 52 Week High/Low: 0.71/0.11
Last Traded: January 27, 2015 10:58 Transaction Volume: 27000
Open: 0.12 Previous Close: 0.135
Bid: 0.115 Ask: 0.12
Bid Size: 78000 Ask Size: 15000
Market Cap: 4.7m Shares Out: 40.9m
PE Ratio: N/A Dividend Yield: N/A

Latest Bullboard Posts

  • InMed Pharmaceuticals

    0 stars

    Looks promising!

    2 stars

  • How does this fit

    0 stars

    I remember hearing IN didn't concern themselves much about the far I have lost 90% of my investment..............I care ...

    2 stars

  • RE:PP

    0 stars

    I think you would be getting one heck of a deal at that offering price. With the relaxing marijuana laws across the globe and the CBD...

    2.5 stars

  • RE:RE:PP

    0 stars

    A 10mil share dilution is peanuts, the market is looking for new IP and size of the dilution indicates a very low burn rate...I'm still...

    1.5 stars

  • RE:PP

    0 stars

    Thanks for the information Hazzard. Very insightful news this pp. I don't have anything to add myself other than to say to the others out...

    3 stars